ArticleCancer communications (London, England)2026

Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences.

Damien Bruyat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.